JP2022535894A5 - - Google Patents
Info
- Publication number
- JP2022535894A5 JP2022535894A5 JP2021572445A JP2021572445A JP2022535894A5 JP 2022535894 A5 JP2022535894 A5 JP 2022535894A5 JP 2021572445 A JP2021572445 A JP 2021572445A JP 2021572445 A JP2021572445 A JP 2021572445A JP 2022535894 A5 JP2022535894 A5 JP 2022535894A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962856863P | 2019-06-04 | 2019-06-04 | |
| US62/856,863 | 2019-06-04 | ||
| US202063011584P | 2020-04-17 | 2020-04-17 | |
| US63/011,584 | 2020-04-17 | ||
| PCT/US2020/036084 WO2020247603A1 (en) | 2019-06-04 | 2020-06-04 | Modified release formulations and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022535894A JP2022535894A (ja) | 2022-08-10 |
| JP2022535894A5 true JP2022535894A5 (https=) | 2023-06-13 |
| JPWO2020247603A5 JPWO2020247603A5 (https=) | 2023-06-13 |
Family
ID=73652146
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021572445A Pending JP2022535894A (ja) | 2019-06-04 | 2020-06-04 | 放出調節製剤およびその使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20220323409A1 (https=) |
| EP (1) | EP3980008A4 (https=) |
| JP (1) | JP2022535894A (https=) |
| WO (1) | WO2020247603A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018378348B2 (en) | 2017-12-05 | 2024-09-19 | Sunovion Pharmaceuticals Inc. | Crystal forms and production methods thereof |
| CA3084953A1 (en) | 2017-12-05 | 2019-06-13 | Sunovion Pharmaceuticals Inc. | Nonracemic mixtures and uses thereof |
| AU2020286441A1 (en) | 2019-06-04 | 2022-01-06 | Sunovion Pharmaceuticals Inc. | Modified release formulations and uses thereof |
| CN115487161B (zh) * | 2022-11-18 | 2023-03-03 | 山东则正医药技术有限公司 | 一种氨磺必利片的制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2762213B1 (fr) * | 1997-04-18 | 1999-05-14 | Synthelabo | Composition pharmaceutique a retention gastrique |
| WO2010023690A2 (en) * | 2008-08-28 | 2010-03-04 | Torrent Pharmaceuticals Ltd. | Prolonged release formulation of amisulpride |
| GB201004020D0 (en) * | 2010-03-11 | 2010-04-21 | Acacia Pharma Ltd | New therapeutic use |
| US10441544B2 (en) * | 2017-10-10 | 2019-10-15 | Douglas Pharmaceuticals, Ltd. | Extended release pharmaceutical formulation |
| CA3084953A1 (en) * | 2017-12-05 | 2019-06-13 | Sunovion Pharmaceuticals Inc. | Nonracemic mixtures and uses thereof |
| AU2020286441A1 (en) * | 2019-06-04 | 2022-01-06 | Sunovion Pharmaceuticals Inc. | Modified release formulations and uses thereof |
-
2020
- 2020-06-04 WO PCT/US2020/036084 patent/WO2020247603A1/en not_active Ceased
- 2020-06-04 EP EP20819312.8A patent/EP3980008A4/en not_active Withdrawn
- 2020-06-04 US US17/616,460 patent/US20220323409A1/en not_active Abandoned
- 2020-06-04 JP JP2021572445A patent/JP2022535894A/ja active Pending